Timely synthetic support for medicinal chemists

Drug Discovery Today

Volumn 10, Issue 2, 2005, Pages 115-120

  Potoski, John ^a  

^a WYETH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSULTATION; CRYSTALLIZATION; DRUG INDUSTRY; DRUG RESEARCH; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MARKET; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PURIFICATION; REVIEW; SCALE UP; SCREENING; SYNTHESIS;

CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; DRUG EVALUATION; DRUG INDUSTRY; PHARMACEUTICAL PREPARATIONS; RESEARCH; TECHNOLOGY, PHARMACEUTICAL;

EID: 13844271915     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(04)03298-2     Document Type: Review

References (24)

1. Golebiowski A., et al. Lead Compounds Discovered from Libraries. Curr. Opin. Chem. Biol. 7:2003;308-325
2. Bunin B.A. Increasing the Efficiency of Small-Molecule Drug Discovery. Drug Discov. Today. 8:2003;823-826
3. Goodnow R.A. Current Practices in Generation of Small Molecule New Leads. J. Cell. Biochem. Suppl. 37:2001;13-21
4. Elands J. The Evolution of Laboratory Automation. Drugs and the Pharmaceutical Sciences. 114:2001;477-492
5. Federsel H. Building Bridges from Process R&D: From a Customer-supplier Relationship to Full Partnership. Pharm. Sci. Technol. Today. 1:1998;387-393
6. Venkatesh S., Lipper R.A. Role of the Development Scientist in Compound Lead Selection and Optimization. J. Pharm. Sci. 89:2000;145-154
7. Lesney M.S. Gearing Up for Speedy Relief. Modern Drug Discovery. 39:2003;39-41
8. Coates W.J., et al. Successful Implementation of Automation in Medicinal Chemistry. Drug Discov. Today. 5:2000;521-527
9. Merritt A.T. Uptake of New Technology in Lead Optimization for Drug Discovery. Drug Discov. Today. 1:1998;505-515
10. Lawrence R.N. Current Approaches to Multiple Parallel Synthesis. Drug Discov. Today. 5:2000;172-175
11. Labaudiniere R.F. RPR's Approach to High-speed Parallel Synthesis for Lead Generation. Drug Discov. Today. 3:1998;511-515
12. Hughes I., Hunter D. Techniques for Analysis and Purification in High Throughput Chemistry. Curr. Opin. Chem. Biol. 5:2001;243-247
13. Kyranos J.N., et al. High-throughput Techniques for Compound Characterization and Purification. Curr. Opin. Drug Discov. Devel. 4:2001;719-728
14. Wess G. Challenges for Medicinal Chemisty. Drug Discov. Today. 1:1996;529-532
15. Hird N.W. Automated Synthesis: New Tools for the Organic Chemist. Drug Discov. Today. 4:1999;265-274
16. Caldwell G.W., et al. Z Yan, The New Pre-Preclinical Paradigm: Compound Optimization in Early and Late Phase Drug Discovery. Curr. Top. Med. Chem. 1:2001;353-366
17. st Century: Approaching the Challenges in the Pharmaceutical Industry. Chirality. 15:2003;S128-S142
18. Curatolo W. Physical Chemical Properties of Oral Drug Candidates in the Discovery and Exploratory Development Settings. Pharm. Sci. Technol. Today. 1:1998;387-393
19. Grant D.J.W., Byrn S.R. A Timely Re-examination of Drug Polymorphism in Pharmaceutical Development and Regulation. Adv. Drug Deliv. Rev. 56:2004;237-239
20. Huang L., Tong W. Impact of Solid State Properties on Developability Assessment of Drug Candidates. Adv. Drug Deliv. Rev. 56:2004;321-334
21. Federsel H. Drug Discoverers - You Need Us! Drug Discov. Today. 6:2001;397-398
22. Shultis K. The Dilemma of Process Development. Drug Discov. Today. 7:2002;850-853
23. Federsel H. Logistics of Process R&D: Transforming Laboratory Methods to Manufacturing Scale. Nat. Rev. Drug Discov. 2:2003;654-664
24. Hillier M.C., Reider P.J. Stereoselective Synthesis from a Process Research Perspective. Drug Discov. Today. 7:2002;303-314